Skip to main content

Cardiovascular disease

Cardiovascular disease

05-18-2018 | Type 2 diabetes | Review | Article

Combination glucose-lowering therapy plans in T2DM: Case-based considerations

Blonde L, Dipp S, Cadena D. Adv Ther 2018. doi: 10.1007/s12325-018-0694-0

05-18-2018 | Gestational diabetes | Review | Article

Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes

Yeung RO et al. Rev Endocr Metab Disord 2018. doi: 10.1007/s11154-018-9446-3

Person holding sweeteners

05-15-2018 | Diet | Article

Glycemic impact of non-nutritive sweeteners: A systematic review and meta-analysis of randomized controlled trials

Nichol AD, Holle MJ, An R. Eur J Clin Nutr 2018. doi: 10.1038/s41430-018-0170-6

05-10-2018 | Devices and technology | Review | Article

Diabetes care in the digital era: A synoptic overview

Fatehi F, Menon A, Bird D. Curr Diab Rep 2018; 18: 38. doi: 10.1007/s11892-018-1013-5

05-09-2018 | Liraglutide (T2DM) | Article

Real-world clinical effectiveness and cost savings of liraglutide versus sitagliptin in treating type 2 diabetes for 1 and 2 years

Li Q et al. Diabetes Ther 2018; Advance online publication. doi: 10.1007/s13300-018-0432-2

05-09-2018 | Sleep apnea | Review | Article

Maternal non-glycemic contributors to fetal growth in obesity and gestational diabetes: Spotlight on lipids

Barbour LA, Hernandez TL. Curr Diab Rep 2018; 18: 37. doi: 10.1007/s11892-018-1008-2

05-08-2018 | Type 2 diabetes | Review | Article

Type 2 diabetes in youth: New lessons from the SEARCH study

Jensen ET, Dabelea D. Curr Diab Rep 2018; 18: 36. doi: 10.1007/s11892-018-0997-1

05-08-2018 | Obesity | Review | Article

Obesity prevention: Strategies and challenges in Latin America

Cominato L et al. Curr Obes Rep 2018; Advance online publication. doi: 10.1007/s13679-018-0311-1

05-05-2018 | Physical activity | Review | Article

May the force be with you: Why resistance training is essential for subjects with type 2 diabetes mellitus without complications

Codella R et al. Endocrine 2018; Advance online publication. doi: 10.1007/s12020-018-1603-7

05-08-2018 | Cardiovascular disorders | Article

Sex-specific relevance of diabetes to occlusive vascular and other mortality: A collaborative meta-analysis of individual data from 980,793 adults from 68 prospective studies

Prospective Studies Collaboration and Asia Pacific Cohort Studies Collaboration. Lancet Diabetes Endocrinol 2018; Advance online publication. doi: 10.1016/S2213-8587(18)30079-2

05-04-2018 | GLP-1 agonists | Review | Article

Glucagon-like peptide 1 in health and disease

Andersen A et al. Nat Rev Endocrinol 2018; Advance online publication. doi: 10.1038/s41574-018-0016-2

05-04-2018 | Gestational diabetes | Article

The post-HAPO situation with gestational diabetes: The bright and dark sides

Lapolla A, Metzger BE. Acta Diabetol 2018; Advance online publication. doi: 10.1007/s00592-018-1146-7

04-18-2018 | Linagliptin | Review | Article

The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes: Focus on linagliptin

Aroor AR, Manrique-Acevedo C, DeMarco VG. Cardiovasc Diabetol 2018; 17: 59. doi: 10.1186/s12933-018-0704-1

04-28-2018 | Heart failure | Review | Article

SGLT2 inhibition and heart failure: Current concepts

Custodio JS et al. Heart Fail Rev 2018; 23: 409–418. doi: 10.1007/s10741-018-9703-2

03-19-2018 | Obesity | News

Further evidence challenges obesity paradox

UK Biobank data add to the evidence challenging the existence of the obesity paradox by showing that cardiovascular disease risk increases linearly with increasing adiposity in middle-aged men and women.

01-11-2018 | Cardiovascular outcomes | Review | Article

Direct cardiovascular impact of SGLT2 inhibitors: Mechanisms and effects

Kaplan A et al. Heart Fail Rev 2018; 23: 419–437. doi: 10.1007/s10741-017-9665-9

12-01-2017 | Obesity | News

Surrogate BMI approach supports overweight mortality risk

A novel approach of using children’s BMI as a surrogate for their parents’ weight confirms that overweight and obesity increase people’s mortality risk.

11-23-2017 | Cardiovascular outcomes | News

Intensive diabetes treatment reduces CVD risk even with excessive weight gain

Intensive treatment of type 1 diabetes appears to reduce the risk for cardiovascular disease events even in those who gain excessive weight, but improved management of cardiovascular risk factors and revascularization may be needed.

09-22-2017 | Physical activity | News

PURE study shows global physical activity benefits

The PURE study shows that the cardiovascular disease and mortality risk reductions attainable with regular physical activity apply regardless of whether people live in countries with high, middle, or low income.